ارسل ملاحظاتك

ارسل ملاحظاتك لنا







Mechanistic Studies on Aziridinyl-Benzoquinones in Cultured Tumour Cells

المصدر: مجلة القلعة
الناشر: جامعة المرقب - كلية الآداب والعلوم بمسلاته
المؤلف الرئيسي: Ben Rabha, Fatma M. (Author)
مؤلفين آخرين: Elashheb, Mabruka S. (Co-Author) , Saeed, Nagat M. (Co-Author) , Hassan, Samia Abd Alkarim Ali (Co-Author) , Ben Saad, Lamees A. (Co-Author)
المجلد/العدد: ع7
محكمة: نعم
الدولة: ليبيا
التاريخ الميلادي: 2017
الشهر: يونيو
الصفحات: 690 - 712
رقم MD: 891630
نوع المحتوى: بحوث ومقالات
اللغة: الإنجليزية
قواعد المعلومات: HumanIndex
مواضيع:
رابط المحتوى:
صورة الغلاف QR قانون

عدد مرات التحميل

2

حفظ في:
المستخلص: This study compares the anti tumour effects of the novel NQO1 activated drug RH1 (2, 5-diaziridinyl-3 -hydoxymethyl-6-methyl-1, 4- benzoquinone) with a novel lipophilic ester derivative Es5 on the isogenic cell lines MDA 468 and MDA 468 NQO1 which differs only in expression of wtNQO1. A 39- fold enhancement of growth inhibitory activity was seen in NQO1 expressing cells compared the NQO1 null cells for the Es5 compared to the 25- fold increase seen for the parent drug, RH1. The kinetics of cell cycle arrest, apoptosis are different in the NQO1 expressing and null cell lines. This indicates a different mechanism of activations and/ or activity for these agents in the presence of active NQO1 protein. We show that Es5 has a higher partition coefficient than RH1, which may enable Es5 to enter the brain. Following cleavage of the ester group Es5 produces a Quinone whose cytoxicity profile is comparable to RH1.